Blood cancer is a group of malignant diseases that affect the blood-forming system, including the bone marrow, blood cells, and the lymphatic system. This group of cancers includes Hodgkin and Non-Hodgkin lymphoma, multiple myeloma, and leukemia, all of which require comprehensive management with high medical standards. To address this need, Mandaya Royal Hospital Puri has launched the Mandaya Blood Cancer Center, developed through a collaboration with the National Cancer Institute Singapore–National University Hospital (NCIS–NUH Singapore), bringing blood cancer treatment protocols and clinical standards comparable to those of leading referral hospitals in Singapore.
Contents
Facilities at the Mandaya Blood Cancer Center
Below are the services and facilities available at the Mandaya Blood Cancer Center:
1. Hematopoietic Stem Cell Transplant (HSCT)
One of the flagship services at the Mandaya Blood Cancer Center is Hematopoietic Stem Cell Transplant (HSCT), a stem cell transplantation procedure aimed at replacing bone marrow damaged by blood cancer with healthy blood-forming stem cells. Through this therapy, the blood cell production process can be restored, helping improve the quality of life of blood cancer patients.
2. ICIR/PICIR Facilities (Immunocompromised Room)
To support the success of HSCT procedures, Mandaya Royal Hospital Puri provides ICIR/PICIR facilities, also known as immunocompromised rooms. These specialized treatment rooms are designed for blood cancer patients with weakened immune systems following HSCT. As part of the HSCT care ecosystem, these rooms help minimize the risk of infection during treatment and recovery.
3. Irradiated Blood Transfusion
The Mandaya Blood Cancer Center also offers irradiated blood transfusion services, which are intended to prevent serious complications such as Transfusion-Associated Graft-Versus-Host Disease (TA-GvHD) in blood cancer patients. This service is particularly crucial for patients who have undergone stem cell transplantation.
4. Comprehensive Systemic Therapy
In the management of blood cancer, a wide range of complete systemic therapy options is available, including chemotherapy, immunotherapy, targeted therapy, and radiotherapy. Each treatment plan is tailored to the patient’s condition and the specific type of blood cancer diagnosed.
5. Digital PET/CT Scan
To support accurate diagnosis and therapy response monitoring, Mandaya Royal Hospital Puri utilizes Digital PET/CT Scan technology. This examination allows doctors to visualize the location, metabolic activity, and spread of cancer cells throughout the body with greater detail and precision.
6. Flow Cytometry Examination
Advanced hematology laboratory examinations, such as flow cytometry, are also performed to analyze the characteristics of blood cancer cells and to evaluate the effectiveness of ongoing treatment.
7. Apheresis Services
As part of comprehensive blood cancer services, Mandaya Royal Hospital Puri provides apheresis procedures. This medical procedure is used to reduce abnormal blood components, such as excessive white blood cells in leukemia patients. Apheresis also allows modification of blood components according to patient needs, helping to control symptoms more rapidly.
KHOM Specialist Team at the Mandaya Blood Cancer Center
Internal medicine specialists with a subspecialty in Medical Hematology-Oncology (KHOM) are physicians who specialize in diagnosing and treating various blood disorders, including blood cancer. Mandaya Royal Hospital Puri is supported by five KHOM specialists who are ready to manage a wide range of blood cancers, including Hodgkin and Non-Hodgkin lymphoma, leukemia, and multiple myeloma.
Below are the five KHOM doctors at the Mandaya Blood Cancer Center:
1. dr. Toman T.J. Lumban Toruan, Sp.PD-KHOM
dr. Toman T.J. Lumban Toruan, Sp.PD-KHOM is an internal medicine specialist with a subspecialty in Medical Hematology-Oncology, experienced in treating various types of blood cancer. He completed his medical education at the Faculty of Medicine, University of Indonesia, followed by an internal medicine specialist program at Cipto Mangunkusumo Hospital. He also participated in an Honorary Fellowship (Clinical Observership) at the Department of Hematology, National University Hospital (NUH), Singapore.
In his clinical practice, dr. Toman is proficient in modern therapies, including chemotherapy, immunotherapy, targeted therapy, and apheresis procedures for specific hematologic disorders.
Practice schedule at Mandaya Royal Hospital Puri:
- Tuesday: 12.00 – 15.00 WIB
- Thursday: 12.00 – 15.00 WIB
2. dr. Alvin Tagor Harahap, Sp.PD-KHOM
dr. Alvin Tagor Harahap, Sp.PD-KHOM is an internal medicine specialist with a subspecialty in Medical Hematology-Oncology who completed his general medical and specialist education at the Faculty of Medicine, University of Indonesia. He has expertise in managing blood cancer and various hematologic disorders using a comprehensive medical approach.
His services include chemotherapy, immunotherapy, targeted therapy, and apheresis procedures, all tailored to the clinical condition and individual needs of each patient.
Practice schedule at Mandaya Royal Hospital Puri:
- Wednesday: 18.00 – 20.00 WIB
- Saturday: 10.00 – 12.00 WIB
3. Prof. DR. Aru W. Sudoyo, Sp.PD-KHOM, FINASIM, FACP
Prof. DR. Aru W. Sudoyo, Sp.PD-KHOM, FINASIM, FACP is one of the most influential hematology and cancer experts in Indonesia. He completed his medical education, internal medicine specialization, and Medical Hematology-Oncology consultancy at the Faculty of Medicine, University of Indonesia, and earned his doctoral degree from the same institution.
Prof. Aru is widely recognized for his contributions to the development of national cancer services. His expertise includes advanced cancer therapies such as chemotherapy, immunotherapy, targeted therapy, bone marrow transplantation, and CAR-T cell therapy.
Practice schedule at Mandaya Royal Hospital Puri:
-
Wednesday: 08.00 – 12.00 WIB
4. Dr. dr. Andree Kurniawan, Sp.PD-KHOM, FINASIM
Dr. dr. Andree Kurniawan, Sp.PD-KHOM, FINASIM is an internal medicine specialist and consultant in Medical Hematology-Oncology with extensive experience in treating blood cancer and hematologic disorders. He is skilled in various therapeutic methods, including chemotherapy, immunotherapy, and targeted therapy.
In his practice, Dr. Andree applies a personalized approach focused on the patient’s clinical needs to achieve optimal treatment outcomes.
Practice schedule at Mandaya Royal Hospital Puri:
- Monday: 17.00 – 19.00 WIB
- Thursday: 17.00 – 19.00 WIB
5. dr. Nia Noviantri Siregar, Sp.PD, Subsp. H-Onk.M (K)
dr. Nia Noviantri Siregar, Sp.PD, Subsp. H-Onk.M (K) is an internal medicine specialist and consultant in Medical Hematology-Oncology who focuses on the treatment of blood cancer and complex hematologic disorders. She has expertise in chemotherapy, immunotherapy, and targeted therapy, applying a comprehensive approach based on the latest medical advancements.
Practice schedule at Mandaya Royal Hospital Puri:
- Tuesday: 17.00 – 20.00 WIB
- Friday: 17.00 – 20.00 WIB
Mandaya–NUH Singapore Collaboration for More Precise Blood Cancer Treatment
The Mandaya Blood Cancer Center at Mandaya Royal Hospital Puri has established a strategic collaboration with the National Cancer Institute Singapore–National University Hospital (NCIS–NUH Singapore) to deliver more precise blood cancer care. This collaboration includes cross-border multidisciplinary case discussions, where each patient is jointly evaluated by medical teams and specialists from Mandaya Royal Hospital Puri and NCIS–NUH Singapore.
Through this process, diagnostic accuracy, therapy effectiveness, and treatment selection can be determined more precisely and tailored to each patient’s individual condition. This partnership also provides patients with access to direct second opinions from internationally experienced blood cancer specialists.
Erwin Suyanto, Public Relations Manager of Mandaya Hospital Group, stated that the launch of the Mandaya Blood Cancer Center reflects Mandaya Royal Hospital Puri’s commitment to delivering cancer services that are not only comprehensive but also integrated with leading global cancer referral centers. According to him, cross-border expert discussions enable more targeted therapy recommendations, thereby continuously improving the quality of care for blood cancer patients.
With comprehensive medical facilities and close collaboration with NCIS–NUH Singapore, Mandaya Royal Hospital Puri further strengthens its position as a leading cancer referral hospital in Indonesia, offering international-standard blood cancer treatment services.
To make your visit to Mandaya Royal Hospital Puri more convenient, you can use the Chat via WhatsApp feature, Book Appointment service, or the Care Dokter application, available for download on Google Play and the App Store, to simplify visits, check queue numbers, and access complete information.
